Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.
- DOI
- 10.2165/11533440-000000000-00000
- Published
- 2010-01-01
- Container
- Clin Drug Investig
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2165/11533440-000000000-00000,
title = {Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.},
author = {Afilalo M and Etropolski MS and Kuperwasser B and Kelly K and Okamoto A and Van Hove I and Steup A and Lange B and Rauschkolb C and Haeussler J.},
year = {2010},
journal = {Clin Drug Investig},
doi = {10.2165/11533440-000000000-00000},
url = {https://doi.org/10.2165/11533440-000000000-00000}
}RIS
TY - JOUR TI - Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study. AU - Afilalo M AU - Etropolski MS AU - Kuperwasser B AU - Kelly K AU - Okamoto A AU - Van Hove I AU - Steup A AU - Lange B AU - Rauschkolb C AU - Haeussler J. PY - 2010 JO - Clin Drug Investig DO - 10.2165/11533440-000000000-00000 UR - https://doi.org/10.2165/11533440-000000000-00000 ER -
APA
M, A., MS, E., B, K., K, K., A, O., I, V. H., A, S., B, L., C, R., & J., H. (2010). Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.. Clin Drug Investig. https://doi.org/10.2165/11533440-000000000-00000
Source records
- europe-pmc · retrieved 2026-09-25T13:58:30.247Z